BY CAROL MARBIN MILLER MIAMI HERLAD The maker of a billion-dollar antipsychotic medication has acknowledged misleading doctors and other healthcare providers about the safety of
A Medical Journal Quandary: How to Report on Drug Trials
THE NEW YORK TIMES By BARRY MEIER The issue of The American Journal of Psychiatry that hit the desks of its 37,000 readers this month
